<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01116882</url>
  </required_header>
  <id_info>
    <org_study_id>DPH00</org_study_id>
    <nct_id>NCT01116882</nct_id>
  </id_info>
  <brief_title>Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings</brief_title>
  <acronym>MASS COMM</acronym>
  <official_title>A Randomized Trial to Compare Percutaneous Coronary Intervention Between Massachusetts Hospitals With Cardiac Surgery-On-Site and Community Hospitals Without Cardiac Surgery-On-Site</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brockton Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Good Samaritan Hospital Medical Center, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwood Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Holy Family Hospital, Methuen, MA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lawrence General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lowell General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Melrose Wakefield Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Metro West Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Saints Memorial Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>South Shore Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Harvard Clinical Research Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the trial is to compare the acute safety and long term outcomes
      between hospitals with cardiac surgery on-site (SOS hospitals) and hospitals without cardiac
      surgery on-site (non-SOS hospitals) for patients with ischemic heart disease treated with
      elective percutaneous coronary intervention (PCI) (stable angina, acute coronary syndrome,
      or non-Q wave MI) presenting to non-SOS hospitals.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The MASS COMM trial is a prospective, multi-center, randomized, controlled two-arm trial of
      PCI performed at non-SOS hospitals (non-SOS-PCI arm) versus PCI performed at SOS hospitals
      (SOS-PCI arm). The trial is designed to reject the null-hypothesis of inferiority, and
      thereby show the non-inferiority of the non-SOS-PCI arm to the SOS-PCI arm.

      Specifically, 3690 subjects will be enrolled in a multi-center, randomized, controlled trial
      (RCT), in which eligible subjects will be consented and randomized in a 3:1 ratio at the
      non-SOS hospitals for PCI to be performed at either the enrolling non-SOS hospital (3
      chances out of 4) or a corresponding SOS hospital (1 chance out of 4).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>30-day Composite Major Adverse Cardiac Event (MACE)</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>12-month Composite Major Adverse Cardiac Event (MACE)</measure>
    <time_frame>12 month</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>All Cause Mortality at 30 Days</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemia-driven Target Lesion Revascularization</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemia-driven Target Lesion Revascularization</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Stent Thrombosis</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any Repeat Revascularization</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Emergency or Urgent Revascularization</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>Post-Procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Procedural success is defined as residual stenosis of the target lesion of less than 20%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Vascular Complications</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complete Revascularization</measure>
    <time_frame>Post-Procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Complete revascularization was defined as the successful treatment, according to the criteria of procedural success, of all epicardial vessels with more than 70% and less than 100% stenosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Met Indication Criteria for PCI</measure>
    <time_frame>Post-Procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Included here are the number of treated lesions that met the class I or II recommendations for anatomical indications for PCI, according to the PCI guidelines fo the American College of Cardiology Foundation-American Heart Association-Society for Cardiovascular Angiography and Interventions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All Cause Mortality at 12 Months</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemia-driven Target Vessel Revascularization</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ischemia-driven Target Vessel Revascularization</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of Stent Thrombosis</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Any Repeat Revascularization</measure>
    <time_frame>30 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3691</enrollment>
  <condition>Coronary Artery Diseases</condition>
  <arm_group>
    <arm_group_label>SOS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to the SOS arm are transferred to tertiary hospitals for their PCI procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-SOS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the non-SOS arm are randomized to stay at the community hospitals for their PCI procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI</intervention_name>
    <arm_group_label>SOS</arm_group_label>
    <arm_group_label>Non-SOS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is at least 18 years old.

          2. Subject requires single- or multi-vessel percutaneous coronary intervention (PCI) of
             de novo or restenotic target lesion (including in-stent restenotic lesions).

          3. Subject's lesion(s) is (are) amenable to stent treatment with currently available
             FDA-approved bare metal or drug eluting stents.

          4. Subject is an acceptable candidate for elective, urgent or emergency coronary artery
             bypass graft (CABG).

          5. Subject has clinical evidence of ischemic heart disease in terms of a positive
             functional study, or documented symptoms.

          6. Documented stable angina pectoris [Canadian Cardiovascular Society Classification
             (CCS) 1, 2, 3, or 4], unstable angina pectoris with documented ischemia (Braunwald
             Class IB-C, IIB-C, or IIIB-C), non-ST segment elevation myocardial infarction, or
             documented silent ischemia.

          7. Subject is willing and able to undergo percutaneous intervention at SOS hospital, if
             randomized to SOS study arm.

          8. Subject and the treating physician agree that the subject will comply with all
             follow-up evaluations.

          9. Subject has been informed of the nature of the study and agrees to its provisions and
             has provided written informed consent as approved by the Institutional Review
             Board/Ethics Committee of the respective clinical site.

         10. The target lesion(s) is (are) de novo or restenotic (including in-stent restenotic)
             native coronary artery lesion(s) with greater than 50 and less than 100% stenosis
             (visual estimate), or the target lesion is an acute (less than 1 month) total
             occlusion as evidenced by clinical symptoms.

         11. Target lesions(s) is (are) located in an infarct (if not treated with primary PCI) or
             non-infarct-related artery with a 70% or greater stenosis (by visual estimate) more
             than 72 hours following the ST segment elevation myocardial infarction (STEMI).

        Lesions treated with PCI more than 72 hours following STEMI would be subject to the same
        protocol inclusion/exclusion criteria listed above and below with the exception that a
        target lesion of 70% or greater stenosis may be treated with or without symptoms or
        abnormal stress test).

        Exclusion Criteria:

          1. The patient is pregnant or breastfeeding.

          2. Evidence of STEMI within 72 hours of the intended treatment on infarct related or
             non-infarct related artery.

          3. Cardiogenic shock on presentation or during current hospitalization.

          4. Left ventricular ejection fraction less than 20%.

          5. Known allergies to: aspirin, clopidogrel (Plavix) and ticlopidine (Ticlid), heparin,
             bivalirudin, stainless steel, or contrast agent (which cannot be adequately
             premedicated).

          6. A platelet count less than 75,000 cells/mm3 or greater than 700,000 cells/mm3 or a
             WBC less than 3,000 cells/mm3.

          7. Acute or chronic renal dysfunction (creatinine greater than 2.5 mg/dl or less than
             150Âµmol/L).

          8. Subject is currently participating in an investigational drug or device study that
             has not completed the primary endpoint or that clinically interferes with the current
             study endpoints. (Note: Trials requiring extended follow-up for products that were
             investigational, but have since become commercially available, are not considered
             investigational trials).

          9. Prior participation in this study.

         10. Within 30 days prior to the index study procedure, the subject has undergone a
             previous coronary interventional procedure of any kind. Note: This exclusion
             criterion does not apply to post-STEMI patients.

         11. Stroke or transient ischemic attack within the prior 3 months.

         12. Active peptic ulcer or upper gastrointestinal bleeding within the prior 3 months.

         13. Subject has active sepsis.

         14. Unprotected left main coronary artery disease (stenosis greater than 50%).

         15. In the investigator's opinion, subject has a co-morbid condition(s) that could limit
             the life expectancy to less than one year, or limit the subject's ability to
             participate in the study or comply with follow-up requirements or impact the
             scientific integrity of the study.

         16. Subject has normal or insignificant coronaries (i.e. coronary lesion(s) less than 50%
             stenosis).

         17. Any target vessel has evidence of:

               -  excessive thrombus (e.g. requires target vessel thrombectomy)

               -  tortuousity (greater than 60 degree angle) that makes it unsuitable for proper
                  stent delivery and deployment,

               -  heavy calcification.

         18. Any target lesion requires treatment with a device other than percutaneous
             transluminal coronary angioplasty (PTCA) prior to stent placement (e.g. but not
             limited to, directional coronary atherectomy, excimer laser, rotational atherectomy,
             etc.).

         19. Any lesion that is located in a saphenous vein graft, however, lesions located within
             the native vessel but accessed through the graft are eligible.

         20. The target vessel is in a &quot;last remaining&quot; epicardial vessel (e.g. greater than 2
             non-target epicardial vessels and the bypass grafts to these territories [if present]
             are totally occluded).
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alice K Jacobs, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston University School of Medicine , Boston Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sharon-Lise Normand, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Laura Mauri, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconnes Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston University Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts New England Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caritas St. Elizabeth's Hospital</name>
      <address>
        <city>Brighton</city>
        <state>Massachusetts</state>
        <zip>02135</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brockton Hospital</name>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caritas Good Samaritan Medical Center</name>
      <address>
        <city>Brockton</city>
        <state>Massachusetts</state>
        <zip>02301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahey Clinic</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Metrowest Medical Center</name>
      <address>
        <city>Framingham</city>
        <state>Massachusetts</state>
        <zip>01702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lawrence General Hospital</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <zip>01803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lowell General Hospital</name>
      <address>
        <city>Lowell</city>
        <state>Massachusetts</state>
        <zip>01854</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saints Memorial Medical Center</name>
      <address>
        <city>Lowell</city>
        <state>Massachusetts</state>
        <zip>01853</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Melrose Wakefield Hospital</name>
      <address>
        <city>Melrose</city>
        <state>Massachusetts</state>
        <zip>02176</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caritas Holy Family Hospital</name>
      <address>
        <city>Methuen</city>
        <state>Massachusetts</state>
        <zip>01844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caritas Norwood Hospital</name>
      <address>
        <city>Norwood</city>
        <state>Massachusetts</state>
        <zip>02062</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Shore Hospital</name>
      <address>
        <city>Weymouth</city>
        <state>Massachusetts</state>
        <zip>02190</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <lastchanged_date>March 18, 2015</lastchanged_date>
  <firstreceived_date>April 29, 2010</firstreceived_date>
  <firstreceived_results_date>June 6, 2014</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PCI</keyword>
  <keyword>heart disease</keyword>
  <keyword>ischemic heart disease</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>PCI at a Hospital Without On-site Cardiac Surgery</title>
          <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
        </group>
        <group group_id="P2">
          <title>PCI at Hospital With On-Site Cardiac Surgery</title>
          <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>30-day</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2774"/>
                <participants group_id="P2" count="917"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2706"/>
                <participants group_id="P2" count="886"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="21"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reasons</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>12-month</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2706"/>
                <participants group_id="P2" count="886"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2439"/>
                <participants group_id="P2" count="787"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="267"/>
                <participants group_id="P2" count="99"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="111"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Reasons</title>
              <participants_list>
                <participants group_id="P1" count="151"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
          <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
        </group>
        <group group_id="B2">
          <title>PCI at Hospital With On-Site Cardiac Surgery</title>
          <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="2774"/>
                <measurement group_id="B2" value="917"/>
                <measurement group_id="B3" value="3691"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="64.71" spread="11.84"/>
                <measurement group_id="B2" value="64.16" spread="11.81"/>
                <measurement group_id="B3" value="64.57" spread="11.83"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="883"/>
                <measurement group_id="B2" value="308"/>
                <measurement group_id="B3" value="1191"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1891"/>
                <measurement group_id="B2" value="609"/>
                <measurement group_id="B3" value="2500"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2526"/>
                <measurement group_id="B2" value="852"/>
                <measurement group_id="B3" value="3378"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="51"/>
                <measurement group_id="B2" value="9"/>
                <measurement group_id="B3" value="60"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Hispanic</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="117"/>
                <measurement group_id="B2" value="35"/>
                <measurement group_id="B3" value="152"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Other</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="80"/>
                <measurement group_id="B2" value="21"/>
                <measurement group_id="B3" value="101"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>30-day Composite Major Adverse Cardiac Event (MACE)</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <population>The denominator for MACE at 30 days is defined as patients who either had MACE to 30d or had follow up of at least 23 days.</population>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2706"/>
                  <measurement group_id="O2" value="886"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>30-day Composite Major Adverse Cardiac Event (MACE)</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="256"/>
                  <measurement group_id="O2" value="83"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>12-month Composite Major Adverse Cardiac Event (MACE)</title>
        <time_frame>12 month</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2439"/>
                  <measurement group_id="O2" value="787"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>12-month Composite Major Adverse Cardiac Event (MACE)</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="421"/>
                  <measurement group_id="O2" value="140"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Cause Mortality at 30 Days</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <population>The denominator for MACE at 30 days is defined as patients who either died to 30d or had follow up of at least 23 days.</population>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2708"/>
                  <measurement group_id="O2" value="885"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>All Cause Mortality at 30 Days</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="18"/>
                  <measurement group_id="O2" value="3"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ischemia-driven Target Lesion Revascularization</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2689"/>
                  <measurement group_id="O2" value="882"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ischemia-driven Target Lesion Revascularization</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="36"/>
                  <measurement group_id="O2" value="12"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ischemia-driven Target Lesion Revascularization</title>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2364"/>
                  <measurement group_id="O2" value="766"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ischemia-driven Target Lesion Revascularization</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="117"/>
                  <measurement group_id="O2" value="38"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Stent Thrombosis</title>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery.</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2364"/>
                  <measurement group_id="O2" value="771"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Rate of Stent Thrombosis</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="27"/>
                  <measurement group_id="O2" value="16"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Repeat Revascularization</title>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2372"/>
                  <measurement group_id="O2" value="769"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Any Repeat Revascularization</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="202"/>
                  <measurement group_id="O2" value="76"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Emergency or Urgent Revascularization</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <population>The denominator for emergency or urgent revascularization at 30 days is defined as patients who either had the event to 30d or had follow up of at least 23 days.</population>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2774"/>
                  <measurement group_id="O2" value="917"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Emergency or Urgent Revascularization</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="7"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedural Success</title>
        <description>Procedural success is defined as residual stenosis of the target lesion of less than 20%</description>
        <time_frame>Post-Procedure</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery in the angiographic cohort</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery in the angiographic cohort</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="289"/>
                  <measurement group_id="O2" value="87"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Procedural Success</title>
            <description>Procedural success is defined as residual stenosis of the target lesion of less than 20%</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="235"/>
                  <measurement group_id="O2" value="65"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Vascular Complications</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2687"/>
                  <measurement group_id="O2" value="882"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Major Vascular Complications</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="13"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complete Revascularization</title>
        <description>Complete revascularization was defined as the successful treatment, according to the criteria of procedural success, of all epicardial vessels with more than 70% and less than 100% stenosis.</description>
        <time_frame>Post-Procedure</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery in the angiographic cohort</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery in the angiographic cohort</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="289"/>
                  <measurement group_id="O2" value="87"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Complete Revascularization</title>
            <description>Complete revascularization was defined as the successful treatment, according to the criteria of procedural success, of all epicardial vessels with more than 70% and less than 100% stenosis.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="174"/>
                  <measurement group_id="O2" value="52"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Met Indication Criteria for PCI</title>
        <description>Included here are the number of treated lesions that met the class I or II recommendations for anatomical indications for PCI, according to the PCI guidelines fo the American College of Cardiology Foundation-American Heart Association-Society for Cardiovascular Angiography and Interventions.</description>
        <time_frame>Post-Procedure</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery in the angiographic cohort</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery in the angiographic cohort</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="289"/>
                  <measurement group_id="O2" value="87"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Lesions analyzed</title>
            <units>Lesions</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="392"/>
                  <measurement group_id="O2" value="106"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Met Indication Criteria for PCI</title>
            <description>Included here are the number of treated lesions that met the class I or II recommendations for anatomical indications for PCI, according to the PCI guidelines fo the American College of Cardiology Foundation-American Heart Association-Society for Cardiovascular Angiography and Interventions.</description>
            <units>lesions</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="369"/>
                  <measurement group_id="O2" value="97"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>All Cause Mortality at 12 Months</title>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2424"/>
                  <measurement group_id="O2" value="785"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>All Cause Mortality at 12 Months</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="56"/>
                  <measurement group_id="O2" value="19"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ischemia-driven Target Vessel Revascularization</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2689"/>
                  <measurement group_id="O2" value="882"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ischemia-driven Target Vessel Revascularization</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="41"/>
                  <measurement group_id="O2" value="13"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ischemia-driven Target Vessel Revascularization</title>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2366"/>
                  <measurement group_id="O2" value="766"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Ischemia-driven Target Vessel Revascularization</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="133"/>
                  <measurement group_id="O2" value="41"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Stent Thrombosis</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2695"/>
                  <measurement group_id="O2" value="883"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Rate of Stent Thrombosis</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="16"/>
                  <measurement group_id="O2" value="7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Any Repeat Revascularization</title>
        <time_frame>30 days</time_frame>
        <safety_issue>No</safety_issue>
        <population>The denominator for any repeat revascularization at 30 days is defined as patients who either had the event to 30d or had follow up of at least 23 days.</population>
        <group_list>
          <group group_id="O1">
            <title>PCI at Hospitals Without On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital without on-site cardiac surgery</description>
          </group>
          <group group_id="O2">
            <title>PCI at Hospital With On-Site Cardiac Surgery</title>
            <description>Assigned to PCI at a hospital with on-site cardiac surgery</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2689"/>
                  <measurement group_id="O2" value="883"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Any Repeat Revascularization</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="73"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Priscilla Driscoll-Shemp</name_or_title>
      <organization>Harvard Clinical Research Institute</organization>
      <phone>617-307-5200</phone>
      <email>priscilla.driscoll-shempp@hcri.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
